Dollar Tree Total Cost of Revenue decreased by 5.3% to $3.14B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $2.99B to $3.14B. Over 2 years (FY 2021 to FY 2025), Total Cost of Revenue shows a downward trend with a -18.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.51B | $4.48B | $4.65B | $4.94B | $4.56B | $4.64B | $4.87B | $5.09B | $5.19B | $5.14B | $2.69B | $2.67B | $2.80B | $3.12B | $2.99B | $3.00B | $3.05B | $3.32B | $3.14B |
| QoQ Change | — | -0.7% | +3.9% | +6.2% | -7.7% | +1.8% | +4.8% | +4.6% | +1.9% | -1.0% | -47.6% | -0.6% | +4.9% | +11.2% | -4.2% | +0.3% | +1.6% | +8.9% | -5.3% |
| YoY Change | — | — | — | — | +1.0% | +3.6% | +4.6% | +11.6% | +11.7% | +5.6% | -47.2% | -48.4% | -45.4% | — | +11.1% | +12.1% | +8.6% | +6.4% | +5.2% |
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| Cost of sales | $2.69B | $2.67B | $2.80B | $3.12B | $2.99B | $3.00B | $3.05B | $3.32B |
| Total | $2.69B | $2.67B | $2.80B | $3.12B | $2.99B | $3.00B | $3.05B | $3.32B |
Cost of sales was previously reported and has since been discontinued or reclassified. Only currently active segments are shown in the chart.